Product image of Luxturna (Voretigene Neparvovec) supplied by GNH India

Luxturna

Active Ingredient:
Voretigene Neparvovec
Origin:
EU

Luxturna (Voretigene Neparvovec)

Luxturna (Voretigene Neparvovec) is a gene therapy designed for inherited retinal diseases. This innovative treatment targets specific genetic mutations to potentially restore vision. Learn more about Luxturna's uses and effects.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Luxturna is used for the treatment of inherited retinal diseases caused by mutations in the RPE65 gene. This gene therapy aims to address vision loss by delivering a functional copy of the RPE65 gene to the retina. Patients with confirmed RPE65 mutation-related retinal dystrophy may be candidates for this treatment.

Side Effects

  • Luxturna works by introducing a functional gene into the retinal cells to potentially improve vision. Common effects may include gradual vision improvement over time, though individual results can vary. Patients should consult their healthcare provider for personalized information.

Precautions & Warnings

  • Luxturna should be administered by healthcare professionals experienced in gene therapy. Patients should discuss their medical history and any current medications with their doctor before treatment. Follow all safety guidelines provided by the healthcare team.

Avoid Interactions

  • Specific drug interactions for Luxturna are not well-documented, but patients should inform their healthcare provider about all medications they are taking. This includes over-the-counter drugs, supplements, and any other treatments. Always follow the advice of a healthcare professional.

Frequently Asked Questions

Luxturna is used to treat inherited retinal diseases caused by mutations in the RPE65 gene, aiming to restore vision.

Luxturna delivers a functional copy of the RPE65 gene to the retina, potentially improving vision in patients with specific genetic mutations.

Candidates for Luxturna typically have confirmed RPE65 mutation-related retinal dystrophy and should be evaluated by a healthcare professional.

Common effects may include gradual vision improvement, though individual results can vary.

Luxturna should be administered by experienced healthcare professionals, and patients should discuss their medical history and current medications with their doctor.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Voretigene Neparvovec

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT